{
    "nct_id": "NCT05428176",
    "official_title": "Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children With Cancer",
    "inclusion_criteria": "* Documented informed consent of the participant and/or legally authorized representative\n\n  * Assent, when appropriate, will be obtained per institutional guidelines\n* Primary participating parent/caregiver is English- or Spanish-speaking (any race/ethnicity)\n* Child is aged 6-12 years (yr.) (for the website usability pre-study, child is age 8 - 12 yrs.)\n* Child understands English (but can be bilingual)\n* Child treated for acute leukemia (e.g., acute lymphoblastic leukemia, acute myelogenous leukemia) or lymphoblastic lymphoma\n* Child is in cancer remission and has completed cancer therapies, including maintenance treatment\n* Primary participating parent/caregiver has daily contact with the child\n* Child is enrolled in school\nHealthy volunteers allowed\nMust have minimum age of 6 Years",
    "exclusion_criteria": "* Recent or current participation in a behavioral intervention study with a similar focus\n* History of major psychiatric condition (e.g., psychosis) in parent or child\n* Severe neurodevelopmental disorder in the child (e.g., down syndrome, intellectual disability)\n* Child has previously used the IXL online learning program extensively and unwilling to regularly use it again\n* Any other condition that would, in the investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures\n* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)",
    "miscellaneous_criteria": ""
}